World Health Organization bids adieu to Hans Hogerzeil – The dynamic Director of Essential Medicines and Pharmaceutical Policies
- 1*
- 1et al. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. JAMA 2001;286:2011-4.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: B. Gitanjali
et al. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. JAMA 2001;286:2011-4.
Email: gitabatman@gmail.com
Copyright: © 2011 The Author(s). This is an open access article.
Abstract
On May 31, 2011, Hans Hogerzeil, Director of Essential Medicines and Pharmaceutical Policies, World Health Organization (WHO), Geneva, received a touching sendoff from the staff and colleagues of WHO, an agency which he had served for 26 years. Hans received his medical degree from the University of Leiden, The Netherlands, and spent his early years as a doctor in India, working in a leprosy mission hospital, and later in a hospital in Ghana, Africa. Hans joined the WHO’s Regional Offi ce for the Eastern Mediterranean (EMRO) in Alexandria, Egypt, in 1985 and worked with Prof. Ranjit Roy Chaudhury for a few years. Later, he joined the WHO Action Programme on Essential Drugs at the WHO headquarters in Geneva and went on to become the Director of Essential Medicines and Pharmaceutical Policies. Hans played a vital role in building on and strengthening the edifi ce built by stalwarts of the essential drugs movement, like Mahler, Lauridsen and Helling-Borda. Hans is well known in India for his book “A guide to good prescribing”, which has been translated into many languages, and its sister publication, “A teacher’s guide to good prescribing”.
Keywords
Subject
Recommended articles
- Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
K. B. Rakesh, Sheetal D. Ullal, B. Sunil Pai · Journal of Pharmacology and Pharmacotherapeutics
- Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods
Sutanaya Pal, Ekta Franscina Pinto, Nitin B. Raut · Journal of Pharmacology and Pharmacotherapeutics
- VACCRaksha Calc: A computer program for the calculation of vaccine potency
D = log10 of the dilution factor · Journal of Pharmacology and Pharmacotherapeutics
- Prescription errors in cancer chemotherapy: Omissions supersede potentially harmful errors
Subodh Kumar · Journal of Pharmacology and Pharmacotherapeutics
- Are we moving towards a new definition of essential medicines?
Marcus M. Reidenberg · Journal of Pharmacology and Pharmacotherapeutics
- European Heart and Rhythm Association guidelines on new oral anticoagulants: A bold step forward
Vishal Sehgal, Sukhminder Jit Singh Bajwa · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026